Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Researchers develop new approach to treating cancer using enzyme therapy

Researchers develop new approach to treating cancer using enzyme therapy

Researchers develop 3D map of the human genome

Researchers develop 3D map of the human genome

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

Researchers launch clinical trial to assess new drug combination against metastatic breast cancers

New personalized cellular therapy approved for use in the European Union

New personalized cellular therapy approved for use in the European Union

HU researchers develop new biological drug that may cure acute myeloid leukemia

HU researchers develop new biological drug that may cure acute myeloid leukemia

Researchers work to create humanized mouse model to test immunotherapies

Researchers work to create humanized mouse model to test immunotherapies

Scientists work towards solving mystery of incurable blood diseases

Scientists work towards solving mystery of incurable blood diseases

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Researchers find STAT3 as therapeutic target for chronic active EBV infection

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

Aravive Biologics gains Fast Track Designation for AVB-S6-500 from U.S. FDA

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

NYU Langone's Perlmutter Cancer Center expands Blood and Marrow Transplant Program

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Study reveals how socioeconomic status affects racial, ethnic disparities in childhood cancer survival

Scientists introduce microfluidics-based chip for manipulation and analysis of single cells

Scientists introduce microfluidics-based chip for manipulation and analysis of single cells

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Study compares survival outcomes in rural and urban cancer patients enrolled in clinical trials

Study provides new insight into how 'trash bag of the cell' traps and seals off waste

Study provides new insight into how 'trash bag of the cell' traps and seals off waste

Study reveals role of RUNX proteins in DNA repair

Study reveals role of RUNX proteins in DNA repair

'Zombie' gene protects elephants from cancer, study finds

'Zombie' gene protects elephants from cancer, study finds

Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia

Scientists identify stress hormone as key factor in failure of immune system to inhibit leukemia

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

‘No one is ever really ready’: Aid-in-dying patient chooses his last day

Scientists discover key vulnerability of mixed lineage leukemia

Scientists discover key vulnerability of mixed lineage leukemia

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

Patients with chronic lymphocytic leukemia have higher risk of melanoma, shows study

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.